Christopher Cassella

ID: 1b83bbcc-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Update on Ophthalmic Anti-VEGF Therapeutics

Big Molecule Watch · October 13, 2023

Update: Post-Trial Briefing in Regeneron v. Mylan Aflibercept BPCIA Case Now Complete

Big Molecule Watch · August 1, 2023

FDA Accepts Xbrane’s sBLA for LUCENTIS® (Ranibizumab) Biosimilar Candidate

Big Molecule Watch · June 28, 2023

Amneal Launches FYLNETRA (pegfilgrastim-pbbk) in the United States

Big Molecule Watch · May 22, 2023

Mabwell Announces Approval of Denosumab Biosimilar MAILISHU in China

Big Molecule Watch · April 20, 2023